Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.7 USD | +0.09% | +0.17% | +239.45% |
May. 06 | Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug | DJ |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | 16.15M | Sales 2025 * | 18.79M | Capitalization | 4.24B |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -113M | EV / Sales 2024 * | 244 x |
Net cash position 2024 * | 304M | Net cash position 2025 * | 208M | EV / Sales 2025 * | 215 x |
P/E ratio 2024 * |
-39.2
x | P/E ratio 2025 * |
-35.2
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.36% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.09% | ||
1 week | +0.17% | ||
Current month | +0.17% | ||
1 month | +85.33% | ||
3 months | +138.75% | ||
6 months | +413.90% | ||
Current year | +239.45% |
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
Director of Finance/CFO | - | 17-05-31 | |
Stanford Peng
PSD | President | 53 | 17-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Conway
BRD | Director/Board Member | 70 | 17-06-30 |
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
James Topper
BRD | Director/Board Member | 62 | 16-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +8.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 64.7 | +0.09% | 747,939 |
24-05-07 | 64.64 | +0.06% | 1,332,282 |
24-05-06 | 64.6 | 0.00% | 1,373,829 |
24-05-03 | 64.6 | 0.00% | 1,924,182 |
24-05-02 | 64.6 | 0.00% | 2,816,786 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+239.45% | 4.24B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- ALPN Stock